Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
DE 102019218587
Kontrastmittelbasierte Gefäßdarstellung
granted -
US 11021542
Humanized BCMA antibody and BCMA-CAR-T cells
granted -
US 11020436
Multipotent and immunocompatible stem cell concentrate
granted -
US 11021465
DNA-PK inhibitors
granted -
US 11020365
Mixture of fatty acids for use in the treatment of inflammatory pathologies
granted -
US 11020403
Precipitation resistant small molecule drug formulations
granted -
US 11020485
Pharmaceutical formulation
granted -
US 11020686
Methods for quantitating individual antibodies from a mixture
granted -
US 11021545
Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer agents
granted -
US 11021517
Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery
granted -
US 11020495
Humanized low affinity FCγR mouse cells
granted -
US 11020345
Nanostraw devices and methods of fabricating and using the same
granted -
US 11022602
Antibiotic-based conjugates and methods of use thereof
granted -
US 11021706
Antisense antibacterial compounds and methods
granted -
US 11021576
Polymeric stabilizing formulations
granted -
US 11021707
Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA
granted -
US 11021696
Nuclease-mediated regulation of gene expression
granted -
US 11021710
Compounds and methods for reducing FXI expression
granted -
US 11021523
Cyanobacteriochromes active in the far-red to near-infrared
granted -
US 11021515
Therapeutically active compounds and their methods of use
granted -
US 11021506
Thiosaccharide mucolytic agents
granted -
US 11021497
Compositions and methods for synthesis of phosphorylated molecules
granted -
US 11021535
Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use
granted -
US 11021481
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.